Project Grant K23MH140073
Award Date 9/1/26
Completion Date 8/31/30
Dollars Obligated $782K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Providence, RI 02906, USA
Similar Awards
- The National Institute of Mental Health awarded Butler Hospital $165,987 on May 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop evidence-based suicide risk management protocols for research involving high-risk populations. The SAFER (Structuring Appropriate and Feasible Evaluations of Risk) project will create and evaluate protocols that balance participant safety with scientific validity in suicide risk research. The study pursues three aims: examining...
- The National Institute of Mental Health awarded Rhode Island Hospital $855,638 on August 20, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a hybrid Type I trial examining the effectiveness of ED_REACH, a family navigation intervention for youth discharged from emergency departments following suicide or non-suicidal self-injurious behavior evaluations. The trial will test ED_REACH (Resilience, Education, and Caregiver Help) with youth and their caregivers,...
- The National Institute of Mental Health awarded Rhode Island Hospital $756,356 on August 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a prospective longitudinal study of parenting practices following psychiatric hospitalization of suicidal adolescents. The study will identify modifiable parenting practices and their impact on self-injurious thoughts and behaviors (SITB) during the first month post-discharge, a period when readmission risk peaks. Rhode...
- The National Institute of Mental Health awarded the University of California, San Diego $793,814 on June 5, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop and evaluate Recovery Integrated Safety and Engagement (RISE), a peer-supported suicide prevention intervention for individuals at clinical high risk for psychosis. The award funds a three-year hybrid Type 1 pilot study at two sites following the Exploration, Preparation, Implementation, Sustainment framework....
- The National Institute of Mental Health awarded the University of Pennsylvania $2.483 million on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to establish the Innovation in Suicide Prevention Research Center (INSPIRE), a research center focused on developing and scaling evidence-based suicide prevention interventions for youth and young adults. INSPIRE will develop and adapt practical suicide prevention interventions for youth and young adults and employ...
- The National Institute of Mental Health awarded Emma Pendleton Bradley Hospital $398,669 on July 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to investigate the relationship between sleep disruption and psychosis-spectrum symptoms in adolescents aged 14–17 years. The research addresses three mechanistic gaps in the literature: the absence of dense sampling across days to measure temporal fluctuations between psychosis-spectrum symptoms and sleep in youth; reliance on...
- The National Institute of Mental Health awarded Research Foundation For Mental Hygiene, Inc. (operating as New York State Psychiatric Institute) $414,186 on August 5, 2026, under the Mental Health Research Grants program (CFDA 93.242) to pilot-test an expanded service delivery model for suicide risk identification and behavioral health treatment linkage among youth on probation. The award funds a three-year hybrid effectiveness-implementation study that augments an existing systems-level...
- The National Institute of Mental Health awarded Trustees of Boston University $188,306 on September 28, 2025, under the Mental Health Research Grants program (CFDA 93.242) to conduct a mixed-methods investigation of loneliness, stigma, and symptom severity in youth aged 14–30 experiencing first-episode psychosis. The research employs ecological momentary assessment (EMA) data to analyze group-level and individualized relationships between loneliness, stigma, and psychosis symptom severity. A...
- The National Institute of Mental Health awarded The General Hospital Corporation (Massachusetts General Hospital) $824,404 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop machine learning models that integrate clinician-conducted suicide risk assessments with electronic health record data to improve prediction of suicidal behavior and guide precision interventions in outpatient behavioral health settings. The research leverages routine clinical...
- The National Institute of Mental Health awarded Indiana University Indianapolis $667,598 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a pilot randomized controlled trial evaluating CAMS-4TEENS, an evidence-based suicide-specific treatment adapted for adolescents involved in the juvenile justice system. The award funds two primary research aims. Aim 1 establishes the feasibility and acceptability of a pilot RCT comparing CAMS-4TEENS to enhanced...